Design, synthesis, in silico ADME, toxicity prediction, molecular docking studies of 1,2,4-oxadiazole incorporated indolizine-thiadiazole derivatives and their biological evaluation as anticancer agents
{"title":"Design, synthesis, in silico ADME, toxicity prediction, molecular docking studies of 1,2,4-oxadiazole incorporated indolizine-thiadiazole derivatives and their biological evaluation as anticancer agents","authors":"Swarupa Ketha , Sudhakar Chithaluri , Shashikala Kethireddy , Laxminarayana Eppakayala , Yahya I. Asiri","doi":"10.1016/j.tet.2025.134709","DOIUrl":null,"url":null,"abstract":"<div><div>A new library of 1,2,4-oxadiazole incorporated indolizine-thiadiazole derivatives (<strong>14a-j)</strong> have been developed and their structures were characterized by <sup>1</sup>HNMR, <sup>13</sup>CNMR and mass spectral data. Further, all compounds were screened for their preliminary anticancer applications towards four human cancer cell lines such as A549 (lung cancer), MCF-7 (breast cancer), Colo-205 (Colon cancer) & A2780 (Ovarian cancer) by using MTT assay, and the well-known chemotherapeutic agent etoposide was used as positive control. The tested compounds showed remarkable anticancer effects on four above mentioned cell lines, ranging from 0.13 ± 0.067 μM to 6.63 ± 2.77 μM, as well as positive control showed values ranges from 0.13 ± 0.017 μM to 3.08 ± 0.135 μM, respectively. Among all the six derivatives <strong>14a, 14b, 14c, 14d, 14i</strong> and <strong>14j</strong> demonstrated strong anticancer activity. Particularly, one compound <strong>14a</strong> displayed prominent activity.</div></div>","PeriodicalId":437,"journal":{"name":"Tetrahedron","volume":"183 ","pages":"Article 134709"},"PeriodicalIF":2.1000,"publicationDate":"2025-05-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tetrahedron","FirstCategoryId":"92","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0040402025002650","RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, ORGANIC","Score":null,"Total":0}
引用次数: 0
Abstract
A new library of 1,2,4-oxadiazole incorporated indolizine-thiadiazole derivatives (14a-j) have been developed and their structures were characterized by 1HNMR, 13CNMR and mass spectral data. Further, all compounds were screened for their preliminary anticancer applications towards four human cancer cell lines such as A549 (lung cancer), MCF-7 (breast cancer), Colo-205 (Colon cancer) & A2780 (Ovarian cancer) by using MTT assay, and the well-known chemotherapeutic agent etoposide was used as positive control. The tested compounds showed remarkable anticancer effects on four above mentioned cell lines, ranging from 0.13 ± 0.067 μM to 6.63 ± 2.77 μM, as well as positive control showed values ranges from 0.13 ± 0.017 μM to 3.08 ± 0.135 μM, respectively. Among all the six derivatives 14a, 14b, 14c, 14d, 14i and 14j demonstrated strong anticancer activity. Particularly, one compound 14a displayed prominent activity.
期刊介绍:
Tetrahedron publishes full accounts of research having outstanding significance in the broad field of organic chemistry and its related disciplines, such as organic materials and bio-organic chemistry.
Regular papers in Tetrahedron are expected to represent detailed accounts of an original study having substantially greater scope and details than that found in a communication, as published in Tetrahedron Letters.
Tetrahedron also publishes thematic collections of papers as special issues and ''Reports'', commissioned in-depth reviews providing a comprehensive overview of a research area.